TransCode Therapeutics (NASDAQ:RNAZ) Given New $20.00 Price Target at HC Wainwright
TransCode Therapeutics (NASDAQ:RNAZ – Get Free Report) had its price target lifted by stock analysts at HC Wainwright from $3.00 to $20.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s price objective would indicate a potential upside of 463.38% […]
More Stories
Torq Resources (CVE:TORQ) Reaches New 52-Week Low – Here’s What Happened
Torq Resources Inc. (CVE:TORQ – Get Free Report) hit a new 52-week low on Wednesday . The company traded as...
Autolus Therapeutics (NASDAQ:AUTL) Stock Price Down 4.4% – Time to Sell?
Autolus Therapeutics plc (NASDAQ:AUTL – Get Free Report) shares traded down 4.4% during mid-day trading on Wednesday . The company...
Oil-Dri Co. of America (NYSE:ODC) Hits New 52-Week High – Here’s What Happened
Oil-Dri Co. of America (NYSE:ODC – Get Free Report) shares reached a new 52-week high during trading on Wednesday ....
Xcel Energy Inc. Declares Quarterly Dividend of $0.55 (NASDAQ:XEL)
Xcel Energy Inc. (NASDAQ:XEL – Get Free Report) announced a quarterly dividend on Wednesday, December 18th,RTT News reports. Shareholders of...
First Trust Large Cap Core AlphaDEX Fund (NASDAQ:FEX) Sees Strong Trading Volume – What’s Next?
First Trust Large Cap Core AlphaDEX Fund (NASDAQ:FEX – Get Free Report) shares saw an uptick in trading volume on...
Micron Technology (NASDAQ:MU) Issues Quarterly Earnings Results, Beats Estimates By $0.19 EPS
Micron Technology (NASDAQ:MU – Get Free Report) announced its quarterly earnings data on Wednesday. The semiconductor manufacturer reported $1.79 earnings...